A combination of pemafibrate and telmisartan, two medications approved in some countries to help manage cardiovascular conditions, may help reduce the buildup of liver fat in people with fatty liver disease, according to a study done in animal models. The study, “Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models […] The post Drug combo shrinks liver fat in rats and zebrafish: Study appeared first on Liver Disease News.
